NEXVOLT Finance Academy Spotlight: Brainlab's €3B MedTech IPO Heats Up German Market
📊 The Numbers That Matter
Brainlab targets €3B valuation at €80-100/share, with €470M revenue and 16.5% EBITDA margin - Germany's 3rd largest IPO this year.
🏥 Surgical Software Dominance
6,700 hospitals across 127 countries rely on Brainlab's mission-critical systems, creating powerful recurring revenue and switching costs.
🇩🇪 German Tech Comeback Story
Founder-controlled (50.1%) with PE backing, this IPO signals renewed confidence in Germany's innovation economy post-downturn.
🔍 Smart Money Positioning
With Berenberg/Deutsche Bank leading the charge, institutional interest is strong ahead of June 23rd bookbuilding.
📚 Learn IPO Strategies with NEXVOLT
Join our official website:
https://www.nxvvj.com/
https://x.com/NEXVOLT_
https://www.instagram.com/nexvolt_/
https://www.facebook.com/Nexvolt/
https://medium.com/@NEXVOLT
